SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-22-004483
Filing Date
2022-03-31
Accepted
2022-03-31 16:56:08
Documents
104
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT admp-10k_123121.htm   iXBRL 10-K 2390976
2 OFFER LETTER BETWEEN THE COMPANY AND DAVID C. BENEDICTO ex10-22.htm EX-10.22 16835
3 FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT ex10-45.htm EX-10.45 20522
4 CONSENT OF BDO USA, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23-1.htm EX-23.1 3317
5 CERTIFICATION BY CEO PURSUANT TO SECTION 302 ex31-1.htm EX-31.1 14875
6 CERTIFICATION BY CFO PURSUANT TO SECTION 302 ex31-2.htm EX-31.2 14753
7 CERTIFICATION BY CEO PURSUANT TO SECTION 906 ex32-1.htm EX-32.1 7069
8 CERTIFICATION BY CFO PURSUANT TO SECTION 906 ex32-2.htm EX-32.2 6830
  Complete submission text file 0001387131-22-004483.txt   10492052

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20211231.xsd EX-101.SCH 70979
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT admp-20211231_cal.xml EX-101.CAL 129899
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT admp-20211231_def.xml EX-101.DEF 280017
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20211231_lab.xml EX-101.LAB 592019
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20211231_pre.xml EX-101.PRE 475024
98 EXTRACTED XBRL INSTANCE DOCUMENT admp-10k_123121_htm.xml XML 1792661
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36242 | Film No.: 22793699
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences